ABSTRACT Aim: Little is known about the concordance rate in twins for dementia with Lewy bodies (DLB). The rate of agreement between clinical and pathological diagnoses for DLB is typically low, necessitating confirmation of the diagnosis neuropathologically. Methods: Participants were 17 twin pairs enrolled in the Duke Twins Study of Memory in Aging in which at least one member of the pair had an autopsy confirmed diagnosis of DLB, Alzheimer's disease (AD) with Lewy bodies or frontotemporal dementia with Lewy bodies. The characteristics of those with dementia were assessed and rates of concordance for pathological confirmed dementia were examined. Results: Four monozygotic twin pairs had a proband with neuropathologically confirmed pure DLB; all remained discordant for dementia for periods up to 16 years or more. Five of 13 pairs in which the proband had AD plus DLB were concordant for dementia but only one pair was concordant for AD plus DLB, while the co-twins in the other four pairs had other types of dementia. Conclusions: The present study indicates that even among twins, a diagnosis of DLB in one twin does not predict the same diagnosis in the other twin. Neuropathological discordance in type of dementia among monozygotic pairs hints at environmental or epigenetic factors playing a role in Lewy body pathology.
Dementia with Lewy bodies (DLB) is reportedly the second most common neurodegenerative dementing disorder. 1 Pathologically, Lewy bodies are distributed throughout the limbic system and neocortex and often co-occur with pathological signs of Alzheimer's Disease (AD). These ''Lewy body variant'' patients may not display the classic clinical phenotype of DLB, making pathological verification necessary for accurate diagnosis.
Genetic factors are important determinants in neurodegenerative diseases, such as AD and Parkinson's disease (PD), but little is known about the genetic predisposition to DLB. Mutations in a-synuclein, b-synuclein and presenilin 1 can cause dementia with Lewy body pathology. [2] [3] [4] Twentythree per cent of individuals with DLB have also been found to have mutations in the lysosomal glucocerebrosidase gene. 5 Despite these reports, most cases of DLB appear to be sporadic. We present a case series of twin pairs in which at least one twin had pathological evidence of DLB.
METHODS Sample
Participants were 11 monozygotic (MZ) and six dizygotic (DZ) twin pairs enrolled in the Duke Twins Study of Memory in Aging in which at least one member of the pair had an autopsy confirmed diagnosis of DLB, AD with Lewy bodies or frontotemporal dementia with Lewy bodies. To be included in the sample, the co-twins with dementia must have had an autopsy for neuropathological diagnosis. Eleven of the twin pairs were members of the National Academy of Sciences-National Research Council (NAS-NRC) Registry of World War II veteran male twins and six pairs were elderly volunteers who had responded to recruitment advertisements for the Duke Twin Studies. Zygosity was determined by blood or buccal DNA samples for nine pairs and in eight pairs from the best available information from questionnaire responses, fingerprint analysis and anthropometric data from military records. APOE genotype was determined from blood or buccal DNA samples.
Dementia assessment and diagnosis
The diagnosis of dementia was determined based on the outcome of a multistep telephone screening and in-person assessment protocol that has been described previously. 6 Members of the NAS-NRC Twin Registry were screened for possible cognitive impairment using a two stage telephone screening protocol. Individuals whose telephone screening indicated possible dementia received a comprehensive in-person dementia evaluation. The diagnostic criteria for DLB have evolved during the 17 years of this study, so information on the currently accepted clinical symptoms associated with DLB 7 were not systematically obtained. We sought to obtain medical records for neuroimaging and laboratory results relevant to the diagnosis.
Members of the volunteer twin sample were screened for cognitive impairment using a telephone interview. Those with suspected dementia were either evaluated in-person (n = 17) or by medical record review to confirm the diagnosis of dementia (n = 5). For both study samples, the cognitively intact co-twins were followed using the telephone screening instruments (n = 7) or inperson assessments (n = 5).
Consensus conferences of specialists in neurology, neuropsychology and geriatric psychiatry assigned final clinical diagnoses based on review of available data. Diagnoses were based on published criteria [7] [8] [9] [10] from the time of their publication forward. We assigned a diagnosis of ''dementia, undetermined aetiology'' when the clinical presentation was too complex or atypical to permit a diagnosis of possible AD but there was no other apparent cause for dementia.
Neuropathological diagnosis
The autopsy evaluations for 14 individuals were done by coinvestigators at Oregon Health and Science University (MJ Ball) and Duke University Medical Center (CMH). For the remaining eight individuals, the neuropathological evaluation was conducted by neuropathologists with expertise in the diagnosis of neurodegenerative diseases throughout the USA. The autopsies spanned from 1992 to 2007, a time period during which the neuropathological criteria for AD and other types of dementia have changed. The diagnostic criteria and the histochemistry procedures reflected the standards at the time the autopsies were done. Either the CERAD 11 or the NIA and Reagan Institute Working Group 12 criteria were used to diagnose AD. According to the protocols which were currently accepted at the centre devoted to AD research, various methods were used to enhance the visibility of neurofibrillary tangles and neuritic diffuse plaques, including tau immunohistochemisty, Abeta immunohistochemisty, Bielschowsky or microwave King silver, congo red, Gallyas, Campbell-Switzer or thioflavine-S.
Sections from the brainstem and cortex were stained for Lewy bodies using ubiquitin or a-synuclein immunohistochemistry. A diagnosis of DLB was made if cortical Lewy bodies (four or more per 2506 field in several fields) were present. 7 In all cases where no Lewy bodies were found, the absence of Lewy bodies was confirmed by immunohistochemical staining for a-synuclein. The diagnosis of Pick's disease was made using immunohistochemistry tau to identify tau positive intraneuronal inclusions (Pick bodies) in the cerebral cortex and basal ganglia. Frontotemporal dementia was diagnosed according to Working Group Criteria. 13 Both cases diagnosed herein with frontotemporal dementia had tau positive inclusions. Table 1 shows the characteristics of the 17 twin pairs. Only one of the twin pairs was concordant for a diagnosis of DLB and this was a MZ pair in which both twins had AD plus DLB. An additional four pairs were concordant for dementia but in these pairs the proband had AD plus DLB while the co-twin had dementia attributable to non-DLB neuropathology. All four MZ pairs in which the proband had neuropathologically confirmed pure DLB remained discordant for dementia. Among the twin pairs discordant for dementia, there were numerous MZ and DZ pairs in which the co-twin remained cognitively intact for 13-22 years after the onset of the proband. The average age of dementia onset was 72 (SD 4.0) years for subjects with pure DLB and 68.4 (8.7) years for subjects with AD+DLB. Spontaneous motor features of parkinsonism were noted in 14 of the 15 individuals who completed an in-person assessment and had Lewy bodies at neuropathology. Ten of 18 individuals with Lewy bodies at neuropathology were reported to have visual hallucinations; three of these individuals had pure DLB. Our methodology did not allow us to determine the time when the parkinsonism symptoms and hallucinations first presented. Review of the history of cognitive decline showed that seven of the individuals with AD+DLB (but none of those with pure DLB) had a rapid decline from mild to severe impairment over a 1 year period. Two of the four twins with pure DLB and nine of the 13 pairs with mixed DLB pathology had a family history of dementia in a first degree relative other than the co-twin. The APOE e4 allele frequency among the four cases with pure DLB was 12.5%, while the e4 allele frequency among those with mixed DLB pathology was 42.3%.
RESULTS

DISCUSSION
We found that concordance for DLB is uncommon in twin pairs when one twin has DLB or mixed DLB-AD pathology. This low rate of concordance was present despite our finding that 59% of the twin pairs had a family history of dementia, which is in agreement with other research. 15 Consistent with another study, 16 we also found that the APOE e4 allele frequency was higher among those with AD+DLB pathology compared with those with pure DLB. However, this may reflect the role of the e4 allele in AD, not in DLB. An inadequate follow-up period due to mortality or other reasons is unlikely to explain our findings given the long period of survival and follow-up for many of these twin pairs. The duration of follow-up of the unaffected co-twins in the present study exceeded the average period of discordance for dementia (ie, about 4 years in MZ pairs and 4-8 years in DZ pairs) reported in the Duke Twins study overall and another large twin sample. 17 Twin studies of AD suggest a multifactorial mode of inheritance with estimates of heritability ranging between 21% and 83%. [17] [18] [19] Twin studies in the early 1980s suggested little to no role of genes in the aetiology of PD, 20 but by 1990, two large kindreds with an autosomal dominant inheritance pattern of PD were identified. 21 Subsequently, data on the NAS-NRC Twin Registry suggested genes play a role in early onset PD (,50 years of age) but not late onset disease 22 while the Swedish twin study reported no evidence for heritability of PD. 23 Although the sample size is small, our results support a limited role for genetic susceptibility in sporadic DLB. But the point should be emphasised that discordance does not exclude a significant genetic contribution to pathogenesis because environmental or epigenetic changes may modify risk. With this in mind, it was interesting that in the present study, four pairs were concordant for dementia but were discordant for Lewy body pathology. One other study on three MZ twin pairs concordant for dementia also found the presence of Lewy body pathology differed within the pairs. 24 There are several limitations to our study that should be noted. Firstly, despite the unique nature of this twin study, our sample size was small, which diminishes our ability to examine environmental factors related to DLB. Clinically, we did not have consistent information on key features, such as onset of hallucinations, behavioural problems and gait disturbance in relation to cognitive disturbance. Such information may have improved our ability to provide antemortem DLB diagnoses and to make clinicopathological correlations. However, we note that clinicopathological agreement has previously been found to be low. 25 We also did not obtain autopsy on the non-demented cotwins. We can confidently state that they did not have dementia but we cannot rule out the possibility that they had some Lewy body pathology.
Post-mortem twin studies are informative but also highlight the complexity and heterogeneity of pathology in dementia. The present study indicates that even among twins, a diagnosis of DLB in one twin does not predict the same diagnosis in the other twin.
